Clicky

Veracyte, Inc.(VCYT) News

Date Title
Apr 17 The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
Apr 17 Should You Continue to Hold Veracyte Stock in Your Portfolio?
Apr 16 Veracyte to Release First Quarter 2025 Financial Results on May 7, 2025
Apr 15 Why Veracyte (VCYT) is a Top Momentum Stock for the Long-Term
Apr 14 Here's Why Veracyte (VCYT) is a Strong Growth Stock
Apr 11 Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain?
Mar 13 Veracyte Stock Surges 45.6% in a Year: What's Driving the Rally?
Mar 10 Veracyte (VCYT) Surged on Reporting Strong Earnings
Mar 4 Veracyte Full Year 2024 Earnings: EPS Misses Expectations
Mar 3 Veracyte's (NASDAQ:VCYT) Performance Is Even Better Than Its Earnings Suggest
Feb 27 Top 3 Medical Instruments Industry Stocks to Ride the GenAI Boom
Feb 24 Veracyte (VCYT) Q4 Earnings and Revenues Beat Estimates
Feb 24 Veracyte: Q4 Earnings Snapshot
Feb 24 Veracyte Announces Fourth Quarter and Full Year 2024 Financial Results
Feb 21 Is Veracyte Stock a Good Addition to Your Portfolio Right Now?
Feb 20 High Growth Tech Stocks To Watch In February 2025
Feb 14 Schrodinger Stock Scores IBD Rating Upgrade
Feb 14 New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research
Feb 13 Best Momentum Stocks to Buy for February 13th
Feb 11 Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU Symposium